Literature DB >> 23908326

Evidence stacks up that endothelial insulin resistance is a culprit in atherosclerosis.

Jenny E Kanter, Karin E Bornfeldt.   

Abstract

Entities:  

Keywords:  Editorial; atherosclerosis; endothelial cell; insulin resistance; protein kinase Cβ

Mesh：

Substances：

Year:  2013        PMID： 23908326      PMCID： PMC3841007          DOI： 10.1161/CIRCRESAHA.113.301998

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  19 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium.

Authors:  Gloria Formoso; Hui Chen; Jeong-a Kim; Monica Montagnani; Agostino Consoli; Michael J Quon
Journal:  Mol Endocrinol       Date:  2005-12-22

3.  Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium.

Authors:  Stefania M C Simeone; Melissa W Li; Pierre Paradis; Ernesto L Schiffrin
Journal:  Physiol Genomics       Date:  2010-11-02       Impact factor: 3.107

4.  Insulin stimulates both endothelin and nitric oxide activity in the human forearm.

Authors:  C Cardillo; S S Nambi; C M Kilcoyne; W K Choucair; A Katz; M J Quon; J A Panza
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

5.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.

Authors:  Christian Rask-Madsen; Qian Li; Bryn Freund; Danielle Feather; Roman Abramov; I-Hsien Wu; Kai Chen; Junko Yamamoto-Hiraoka; Jan Goldenbogen; Konstantinos B Sotiropoulos; Allen Clermont; Pedro Geraldes; Claudia Dall'Osso; Amy J Wagers; Paul L Huang; Mark Rekhter; Rosario Scalia; C Ronald Kahn; George L King
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

6.  Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance.

Authors:  Keiko Naruse; Christian Rask-Madsen; Noriko Takahara; Sung-woo Ha; Kiyoshi Suzuma; Kerrie J Way; Judith R C Jacobs; Allen C Clermont; Kohjiro Ueki; Yuzuru Ohshiro; Junqing Zhang; Allison B Goldfine; George L King
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

7.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

Authors:  M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

8.  Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.

Authors:  Evis Harja; Jong Sun Chang; Yan Lu; Michael Leitges; Yu Shan Zou; Ann Marie Schmidt; Shi-Fang Yan
Journal:  FASEB J       Date:  2008-11-26       Impact factor: 5.191

9.  The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.

Authors:  Afroze Abbas; Helen Imrie; Hema Viswambharan; Piruthivi Sukumar; Adil Rajwani; Richard M Cubbon; Matthew Gage; Jessica Smith; Stacey Galloway; Nadira Yuldeshava; Matthew Kahn; Shouhong Xuan; Peter J Grant; Keith M Channon; David J Beech; Stephen B Wheatcroft; Mark T Kearney
Journal:  Diabetes       Date:  2011-06-15       Impact factor: 9.461

10.  eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice.

Authors:  Padmapriya Ponnuswamy; Angelika Schröttle; Eva Ostermeier; Sabine Grüner; Paul L Huang; Georg Ertl; Ulrich Hoffmann; Bernhard Nieswandt; Peter J Kuhlencordt
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240
View more
  6 in total

1.  Skeletal muscle microvascular insulin resistance in type 2 diabetes is not improved by eight weeks of regular walking.

Authors:  Lauren K Park; Elizabeth J Parks; Ryan J Pettit-Mee; Makenzie L Woodford; Thaysa Ghiarone; James A Smith; Allan R K Sales; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla
Journal:  J Appl Physiol (1985)       Date:  2020-07-02

2.  miR-29a promotes myocardial cell apoptosis induced by high glucose through down-regulating IGF-1.

Authors:  Chunli Han; Xiaochao Chen; Renwei Zhuang; Mingtong Xu; Shulei Liu; Qiwen Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice.

Authors:  Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

Review 4.  Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance.

Authors:  Manna Li; Ming Qian; Jian Xu
Journal:  Front Cardiovasc Med       Date:  2017-08-09

5.  The GG genotype of telomerase reverse transcriptase at genetic locus rs2736100 is associated with human atherosclerosis risk in the Han Chinese population.

Authors:  Lei Feng; Shi-Yan Nian; Jihong Zhang
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

6.  Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients.

Authors:  Hui Peng; Meirong Zhong; Wenbo Zhao; Cheng Wang; Jun Zhang; Xun Liu; Yuanqing Li; Sujay Dutta Paudel; Qianqian Wang; Tanqi Lou
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.